Australian Radiation Protection and Nuclear Safety Act 1998
Notice of intention to make a decision on a facility licence application
Pursuant to sub-regulation 40(2) of the Australian Radiation Protection and Nuclear Safety Regulations 1999, the CEO of the Australian Radiation Protection and Nuclear Safety Agency intends to make a decision under section 32 of the Australian Radiation Protection and Nuclear Safety Act 1998 regarding the following application for a facility licence:
Application No. A0320 from Australian Radiation Protection and Nuclear Safety Agency, Medical Radiation Services to construct a Radiation Prescribed Facility at 619 Lower Plenty Rd, Yallambie Victoria 3085.
The facility will be a particle accelerator (linear accelerator) with a beam energy of more than 1 MeV and will be used as a national facility for calibration of radiotherapy linear accelerators in Australia and overseas.
Overview
The Australian Radiation Protection and Nuclear Safety Act 1998, enacted by the Parliament of Australia, was introduced to ensure the protection of people, the community, and the environment from the harmful effects of ionising radiation and to regulate the use of nuclear substances and facilities. The Act establishes a framework for the regulation of radiation practices, including the licensing of facilities and the control of nuclear activities. The policy objective of the Act is to provide for effective protection against the risks associated with radiation and nuclear activities, while facilitating the beneficial uses of radiation and nuclear technology. In accordance with the Act, the CEO of the Australian Radiation Protection and Nuclear Safety Agency intends to make a decision on a facility licence application for the construction of a particle accelerator facility at 619 Lower Plenty Rd, Yallambie, Victoria. This facility will serve as a national resource for the calibration of radiotherapy linear accelerators, both domestically and internationally.
Scope and Application
The Australian Radiation Protection and Nuclear Safety Act 1998 applies to entities and persons involved in the use, production, and handling of radioactive substances and nuclear materials within Australia. It is applicable to the construction, operation, and decommissioning of facilities that use or produce radioactive materials, and it regulates activities such as the transportation and disposal of these materials. The Act covers both Commonwealth and state jurisdictions, providing a comprehensive framework for the safe and responsible use of radiation and nuclear substances. The Act's reach extends to facilities and activities that are not explicitly excluded by subordinate instruments, which may further specify details such as licensing requirements, safety standards, and enforcement mechanisms. Any exemptions or exclusions are clearly defined in the regulations and guidelines provided under the Act. The CEO of the Australian Radiation Protection and Nuclear Safety Agency, who intends to make a decision on the facility licence application for the construction of a radiation prescribed facility in Yallambie, Victoria, operates within the scope of this Act.
Key Provisions
The main operative sections of the Australian Radiation Protection and Nuclear Safety Act 1998 (the Act) pertinent to this case involve the procedures and requirements for the application and assessment of a facility licence (section 32). Under this section, the CEO of the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) is empowered to make decisions on applications for such licences, ensuring that the proposed facility complies with the regulations and standards set forth by the Act. Additionally, sub-regulation 40(2) of the Australian Radiation Protection and Nuclear Safety Regulations 1999 mandates that ARPANSA must notify the applicant of its intention to make a decision on the licence application, as is the case with Application No. A0320 from ARPANSA, Medical Radiation Services.
The Act imposes several obligations and requirements on the parties involved in the facility licence application process. Firstly, the applicant, in this case ARPANSA, Medical Radiation Services, must submit a comprehensive application that includes detailed plans and specifications of the proposed facility, risk assessments, and compliance with all relevant safety and radiation protection standards. The applicant must also ensure that the facility, which in this instance is a particle accelerator with a beam energy of more than 1 MeV, adheres to all statutory requirements and does not pose any undue risk to the public or the environment. Furthermore, the applicant is required to provide any additional information or documentation requested by ARPANSA during the assessment process.
Failure to comply with the provisions of the Act or the associated regulations can result in significant legal consequences. For example, if the facility poses a risk to public health and safety, the CEO of ARPANSA may refuse to grant the licence. Additionally, the Act provides for the imposition of fines and other penalties for breaches of its provisions. Specifically, section 406 of the Act outlines various offences, including the unauthorised use of a radiation source or a facility, and imposes penalties that can include substantial fines or imprisonment for serious breaches. The maximum penalty for contravening certain sections of the Act can reach up to $1.65 million for corporations and lesser amounts for individuals, depending on the severity and nature of the breach. These provisions ensure that all parties adhere to the highest standards of radiation protection and nuclear safety.